March 27, 2016
Philpot publishes lab’s research in Neuron
The results suggest further lines of research related to the effects of neurodevelopmentally critical genes on other kinds of neurons.
Tag: Philpot news
February 18, 2016
Philpot and Stuber labs discover a role for GABA co-release in the brain鈥檚 reward pathway
In a paper published in Nature Communications, Janet Berrios, a graduate student in the Philpot lab, discovered that the loss of UBE3A decreases the release of the GABA neurotransmitter and alters reward-seeking behavior in an important neural pathway once presumed to be principally regulated by the dopamine neurotransmitter.
January 26, 2016
Zylka and Philpot to lead 黑料网 Neuroscience Center
Mark Zylka, PhD, will serve as director and Ben Philpot, PhD, will serve as associate director of the 黑料网 Neuroscience Center at the 黑料网, effective July 1. William Snider, MD, who has served as the center鈥檚 director for nearly 17 years, will step down from his leadership role, but will remain on faculty as professor of neurology, while also continuing his research.
February 3, 2014
Ben Philpot receives new R01 funding
January 2014 鈥� Congratulations to Professor Ben Philpot, PhD, for receiving a new R01 entitled 鈥淩ole of UBE3A in the Central Nervous System.鈥�
August 19, 2013
Thaxton awarded two-year NARSAD Young Investigator grant
The Brain & Behavior Research Foundation (formerly known as NARSAD, or the National Alliance for Research on Schizophrenia and Depression) awards $11.8 million in 200 new two-year grants for young researchers in brain and behavior science.
October 12, 2012
Philpot lab publishes cover story in the journal Neuron
October 2012 - A new activity-dependent role for the protein heavily implicated in autism, Neuroligin-1, identified
June 6, 2012
Philpot lab publication in the journal Neuron outlines how brain cell activity imbalance may account for seizure susceptibility in Angelman syndrome
New research by Philpot lab researchers may have pinpointed an underlying cause of the seizures that affect 90 percent of people with Angelman syndrome (AS), a neurodevelopmental disorder.
April 19, 2012
Philpot and Snider awarded $2 million to study roots of cognitive disabilities
April 2012 -Philpot and Snider will study the cognitive disabilities in patients with RAS/MARK syndromes.
December 21, 2011
Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth
December 2011 - Collaborators Ben Philpot, Mark Zylka and Bryan Roth identify compounds that cause the dormant Ube3a gene to be expressed.
December 21, 2011
Philpot lab news is top news at Simons Foundation Autism Research Initiative
December 2011 - Recent work on Ube3a is most viewed on Simons Foundation Autism Research Initiative website.